All

Sep 1 2008

Microbicide delivery: formulation technologies and strategies

Romano J., Malcolm R.K., Garg S., Rohan L.C., Kaptur P.E. Current Opinion HIV/AIDS 3 (2008): 558-66 More »

Aug 3 2008

Microbicides Access Forum 2008 Final Report

The report from the second Microbicide Access Forum (MAF) offers a detailed summary of discussion evaluating the current state of access planning, and lessons learned from the introduction of health... More »

Apr 15 2008

Vaginal microbicides: What does the future hold?

Cates W., Rosenberg Z. Contemporary OB/GYN Supplement. April 15, 2008. More »

Apr 1 2008

A randomized six-day safety study of an antiretroviral microbicide candidate UC781, a non-nucleoside reverse transcriptase inhibitor.

Schwartz J.L., Kovalevsky G., Lai J.J., Ballagh S.A., McCormick T., Douville K., Mauck C.K., Callahan M.M. Sexually Transmitted Diseases 35, no. 4 (2008): 414-9. More »

Mar 1 2008

Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C] dapivirine for 7 days.

Nuttall J.P., Thake D.C., Lewis M.G., Ferkany J.W., Romano J.W., Mitchnick M.A. Antimicrobial Agents and Chemotherapy 52, no. 3(2008) :909-14. More »

Pages